ResearcherMayo ClinicNo recent work listed
Gehan Botrus
Matched on ORCID iD 0000-0002-6477-3948; OpenAlex author ID A5070195096. Sources: ClinicalTrials.gov.
Their work
- Papers
- 5
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 trial · 2020: none · 2021: 2 papers · 2022: 3 papers
Papers 5
- Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis. Co-author DOI 10.1038/s41598-022-17743-6↗
- Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Based Chemotherapy and Olaparib. Co-author DOI 10.3390/biomedicines10112705↗
- Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR). Co-author DOI 10.3390/ijms24010577↗
- Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma. Co-author DOI 10.1002/onco.13717↗
- Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. Co-author DOI 10.3389/fonc.2021.794009↗
Trials 1
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pedro Luiz Serrano Usón · 5 shared papers, 2021–2022 · strength 0.69
- Paper Increasing Stress to Induce Apoptosis in Pancreatic Cancer via the Unfolded Protein Response (UPR). DOI 10.3390/ijms24010577↗
- Paper Mitomycin C in Homologous Recombination Deficient Metastatic Pancreatic Cancer after Disease Progression on Platinum-Ba… DOI 10.3390/biomedicines10112705↗
- Paper Neoadjuvant chemotherapy or upfront surgery in localized pancreatic cancer: a contemporary analysis. DOI 10.1038/s41598-022-17743-6↗
- Mitesh J. Borad · 2 shared papers, 2021 · strength 0.21
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Paper Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. DOI 10.3389/fonc.2021.794009↗
- Daniel H. Ahn · 2 shared papers, 2021 · strength 0.21
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Paper Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. DOI 10.3389/fonc.2021.794009↗
- Mohamad Bassam Sonbol · 2 shared papers, 2021 · strength 0.21
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Paper Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. DOI 10.3389/fonc.2021.794009↗
- Jason Scott Starr · 2 shared papers, 2021 · strength 0.21
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Paper Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. DOI 10.3389/fonc.2021.794009↗
- Tanios Bekaii‐Saab · 2 shared papers, 2021 · strength 0.21
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Paper Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. DOI 10.3389/fonc.2021.794009↗
- Kabir Mody · 2 shared papers, 2021 · strength 0.21
- Paper Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenoca… DOI 10.1002/onco.13717↗
- Paper Circulating Cell-Free Tumor DNA in Advanced Pancreatic Adenocarcinoma Identifies Patients With Worse Overall Survival. DOI 10.3389/fonc.2021.794009↗
- Haiyong Han · 1 shared paper, 2022 · strength 0.19
- Daniel D. Von Hoff · 1 shared paper, 2022 · strength 0.19
- Gayle Jameson · 1 shared paper, 2022 · strength 0.16
- Ronald Lee Korn · 1 shared paper, 2022 · strength 0.16
- Erkut Hasan Borazanci · 1 shared paper, 2022 · strength 0.16
- Fernando Moura · 1 shared paper, 2022 · strength 0.14
- Pashtoon Murtaza Kasi · 1 shared paper, 2021 · strength 0.11
- Umair Majeed · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.